Bozzi and colleagues [89] showed that EGFR and platelet-derived growth factor receptors (PDGFRA and PDGFRB) are upregulated in SS with subsequent PI3K/AKT/mTOR pathway activation. This evidence concerns the gene EGFR and synovial sarcoma.